Abstract
When naive mice receive short Zfra peptides via tail vein injections, they develop lifetime resistance to growth of many cancer xenografts, due to activation of a novel spleen memory Hyal-2+ CD3– CD19− Z lymphocyte. In vitro education of spleen cells with Zfra activates Z cell for conferring memory anticancer response in vivo.
Original language | English |
---|---|
Article number | e1213935 |
Journal | OncoImmunology |
Volume | 5 |
Issue number | 9 |
DOIs | |
Publication status | Published - 2016 Sept 1 |
All Science Journal Classification (ASJC) codes
- Immunology and Allergy
- Immunology
- Oncology